Top broker tips Allkem share price to jump 80%

Allkem's shares could be heading a lot higher according to one broker…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Allkem Ltd (ASX: AKE) share price has been having a tough time of late.

Due to the market volatility, this lithium producer's shares have lost 25% of their value since this time last month.

In light of this, some investors may be wondering if the Allkem share price weakness has created a buying opportunity.

A man wearing a suit holds his arms aloft, attached to a large lithium battery with green charging symbols on it.

Image source: Getty Images

Is the Allkem share price good value now?

According to a note out of Bell Potter this morning, its analysts have reiterated their buy rating with a trimmed price target of $17.53.

Based on the current Allkem share price of $9.85, this implies potential upside of 78% for investors over the next 12 months.

Why is the broker bullish?

Bell Potter is bullish on Allkem due to its equally bullish view on lithium prices.

Unlike some analysts, the team at Bell Potter is expecting lithium prices to remain strong for the foreseeable future thanks to market deficits caused by increasing demand for the battery making material.

Combined with its growing production, the broker expects this to boost Allkem's cash generation and profits materially in the coming years.

Bell Potter explained:

We expect AKE's near term cash generation to lift substantially into 2023 as strength in lithium commodity indices flows through to lagged realised prices. AKE is aiming to maintain 10% share of supply in a global lithium market experiencing unprecedented growth; it has a portfolio of growth projects, balance sheet strength and cash flow from existing projects to achieve this. On our estimates, lithium demand will lift from current levels of around 500ktpa to over 1.1Mtpa in 2025 and more than 3.2Mtpa by 2030, driving market deficits and strong lithium pricing.

As for its profits, the broker is forecasting a reported net profit of US$309 million in FY 2022. After which, it expects Allkem's net profit to lift to US$680 million in FY 2023 and US$912 million in FY 2024.

All in all, this could make Allkem a share to consider if you're looking for lithium exposure.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »